Endothelial heparan sulfate in angiogenesis

Progress in Molecular Biology and Translational Science

Volumn 93, Issue C, 2010, Pages 179-212

  Fuster, Mark M ^a,b   Wang, Lianchun ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Angiogenesis; Cancer; Endothelial cell; Growth factor; Heparan sulfate; Mural cells; PDGF B; Pericyte; TGF ; VEGF A

Indexed keywords

HEPARAN SULFATE;

ANGIOGENESIS; ANIMAL; HUMAN; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HEPARITIN SULFATE; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 77958168593     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)93009-3     Document Type: Chapter

References (138)

1. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936
2. L. Coultas, K. Chawengsaksophak, and J. Rossant Endothelial cells and VEGF in vascular development Nature 438 2005 937 945
3. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
4. C. Suri, P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, and S. Davis Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 1996 1171 1180
5. J.A. Alva, and M.L. Iruela-Arispe Notch signaling in vascular morphogenesis Curr Opin Hematol 11 2004 278 283
6. T.N. Sato Vascular development: molecular logic for defining arteries and veins Curr Opin Hematol 10 2003 131 135
7. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
8. R.K. Jain Molecular regulation of vessel maturation Nat Med 9 2003 685 693
9. C.J. Drake Embryonic and adult vasculogenesis Birth Defects Res C Embryo Today 69 2003 73 82
10. T.S. Stappenbeck, L.V. Hooper, and J.I. Gordon Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells Proc Natl Acad Sci USA 99 2002 15451 15455
11. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, and M. Gertsenstein Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
12. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
13. A.W. Griffioen, and G. Molema Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol Rev 52 2000 237 268
14. M. Bernfield, M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, and J. Lincecum Functions of cell surface heparan sulfate proteoglycans Annu Rev Biochem 68 1999 729 777
15. J.D. Esko, and S.B. Selleck Order out of chaos: assembly of ligand binding sites in heparan sulfate Annu Rev Biochem 71 2002 435 471
16. J.R. Bishop, M. Schuksz, and J.D. Esko Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446 2007 1030 1037
17. E. Forsberg, and L. Kjellen Heparan sulfate: lessons from knockout mice J Clin Invest 108 2001 175 180
18. A.C. Rapraeger Heparan sulfate-growth factor interactions Methods Cell Biol 69 2002 83 109
19. L. Kjellen Glucosaminyl N-deacetylase/N-sulphotransferases in heparan sulphate biosynthesis and biology Biochem Soc Trans 31 2003 340 342
20. J.D. Esko, and U. Lindahl Molecular diversity of heparan sulfate J Clin Invest 108 2001 169 173
21. S.E. Stringer The role of heparan sulphate proteoglycans in angiogenesis Biochem Soc Trans 34 2006 451 453
22. M. Presta, P. Dell'Era, S. Mitola, E. Moroni, R. Ronca, and M. Rusnati Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev 16 2005 159 178
23. R.V. Iozzo, and J.D. San Antonio Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena J Clin Invest 108 2001 349 355
24. J. Ledin, W. Staatz, J.P. Li, M. Gotte, S. Selleck, and L. Kjellen Heparan sulfate structure in mice with genetically modified heparan sulfate production J Biol Chem 279 2004 42732 42741
25. B.L. Allen, M.S. Filla, and A.C. Rapraeger Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition J Cell Biol 155 2001 845 858
26. D. Stenzel, E. Nye, M. Nisancioglu, R.H. Adams, Y. Yamaguchi, and H. Gerhardt Peripheral mural cell recruitment requires cell-autonomous heparan sulfate Blood 114 2009 915 924
27. G. Fan, L. Xiao, L. Cheng, X. Wang, B. Sun, and G. Hu Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice FEBS Lett 467 2000 7 11
28. S.R Pallerla, Y. Pan, X. Zhang, J.D. Esko, and K. Grobe Heparan sulfate Ndst1 gene function variably regulates multiple signaling pathways during mouse development Dev Dyn 236 2007 556 563
29. M. Ringvall, J. Ledin, K. Holmborn, T. van Kuppevelt, F. Ellin, and I. Eriksson Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1 J Biol Chem 275 2000 25926 25930
30. A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, and E. Schallmeiner Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes Dev 21 2007 316 331
31. M.M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, and P.H. Lee Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J Cell Biol 177 2007 539 549
32. L. Wang, M. Fuster, P. Sriramarao, and J.D. Esko Endothelial heparan sulfate deficiency impairs l-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses Nat Immunol 6 2005 902 910
33. J.P. Li, F. Gong, A. Hagner-McWhirter, E. Forsberg, M. Abrink, and R. Kisilevsky Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking l-iduronic acid and in neonatal lethality J Biol Chem 278 2003 28363 28366
34. E. Chen, S.E. Stringer, M.A. Rusch, S.B. Selleck, and S.C. Ekker A unique role for 6-O sulfation modification in zebrafish vascular development Dev Biol 284 2005 364 376
35. H. Habuchi, N. Nagai, N. Sugaya, F. Atsumi, R.L. Stevens, and K. Kimata Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality J Biol Chem 282 2007 15578 15588
36. K.I. Izvolsky, J. Lu, G. Martin, K.H. Albrecht, and W.V. Cardoso Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis Genesis 46 2008 8 18
37. S. HajMohammadi, K. Enjyoji, M. Princivalle, P. Christi, M. Lech, and D. Beeler Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis J Clin Invest 111 2003 989 999
38. A. de Agostini An unexpected role for anticoagulant heparan sulfate proteoglycans in reproduction Swiss Med Wkly 136 2006 583 590
39. P. Carmeliet, YS Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, and I. Cornelissen Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 1999 495 502
40. C. Ruhrberg, H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, and H. Fujisawa Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis Genes Dev 16 2002 2684 2698
41. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, and A. Abramsson VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 2003 1163 1177
42. G.H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
43. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, and M.L. Breitman Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
44. P. Lindblom, H. Gerhardt, S. Liebner, A. Abramsson, M. Enge, and M. Hellstrom Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall Genes Dev 17 2003 1835 1840
45. P. Lindahl, B.R. Johansson, P. Leveen, and C. Betsholtz Pericyte loss and microaneurysm formation in PDGF-B-deficient mice Science 277 1997 242 245
46. A. Abramsson, P. Lindblom, and C. Betsholtz Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors J Clin Invest 112 2003 1142 1151
47. M. Hellstrom, H. Gerhardt, M. Kalen, X. Li, U. Eriksson, and H. Wolburg Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis J Cell Biol 153 2001 543 553
48. M.J. Goumans, and C. Mummery Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice Int J Dev Biol 44 2000 253 265
49. A.G. Marneros, and B.R. Olsen Physiological role of collagen XVIII and endostatin FASEB J 19 2005 716 728
50. A. Clamp, F.H. Blackhall, A. Henrioud, G.C. Jayson, K. Javaherian, and J. Esko The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate J Biol Chem 281 2006 14813 14822
51. R.C. Reis, D. Schuppan, A.C. Barreto, M. Bauer, J.P. Bork, and G. Hassler Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans Biochem Biophys Res Commun 333 2005 976 983
52. S. Gaetzner, M.M. Deckers, S. Stahl, C. Lowik, B.R. Olsen, and U. Felbor Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants Matrix Biol 23 2005 557 561
53. K. Kamimura, M. Fujise, F. Villa, S. Izumi, H. Habuchi, and K. Kimata Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system J Biol Chem 276 2001 17014 17021
54. H. Nakato, and K. Kimata Heparan sulfate fine structure and specificity of proteoglycan functions Biochim Biophys Acta 1573 2002 312 318
55. M. Ford-Perriss, SE Guimond, U. Greferath, M. Kita, K. Grobe, and H. Habuchi Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling Glycobiology 12 2002 721 727
56. K. Grobe, J. Ledin, M. Ringvall, K. Holmborn, E. Forsberg, and J.D. Esko Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes Biochim Biophys Acta 1573 2002 209 215
57. T. Yabe, T. Hata, J. He, and N. Maeda Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain Glycobiology 15 2005 982 993
58. E. Forsberg, G. Pejler, M. Ringvall, C. Lunderius, B. Tomasini-Johansson, and M. Kusche-Gullberg Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme Nature 400 1999 773 776
59. K. Grobe, M. Inatani, S.R. Pallerla, J. Castagnola, Y. Yamaguchi, and J.D. Esko Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function Development 132 2005 3777 3786
60. M. Inatani, F. Irie, A.S. Plump, M. Tessier-Lavigne, and Y. Yamaguchi Mammalian brain morphogenesis and midline axon guidance require heparan sulfate Science 302 2003 1044 1046
61. D.C. Kraushaar, Y. Yamaguchi, and L. Wang Heparan sulfate is required for embryonic stem cells to exit form self-renewal J Biol Chem 285 2009 5907 5916
62. X. Lin, G. Wei, Z. Shi, L. Dryer, J.D. Esko, and D.E. Wells Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice Dev Biol 224 2000 299 311
63. R. Munoz-Chapuli, A.R. Quesada, and M. Angel Medina Angiogenesis and signal transduction in endothelial cells Cell Mol Life Sci 61 2004 2224 2243
64. S. Soker, S. Takashima, H.Q. Miao, G. Neufeld, and M. Klagsbrun Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 1998 735 745
65. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
66. B.A. Keyt, L.T. Berleau, H.V. Nguyen, H. Chen, H. Heinsohn, and R. Vandlen The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency J Biol Chem 271 1996 7788 7795
67. N. Cheung, M.P. Wong, S.T. Yuen, S.Y. Leung, and L.P. Chung Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon Hum Pathol 29 1998 910 914
68. L. Jakobsson, J. Kreuger, K. Holmborn, L. Lundin, I. Eriksson, and L. Kjellen Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis Dev Cell 10 2006 625 634
69. W.J. LaRochelle, M. May-Siroff, K.C. Robbins, and S.A. Aaronson A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain Genes Dev 5 1991 1191 1199
70. A. Ostman, M. Andersson, C. Betsholtz, B. Westermark, and C.H. Heldin Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain Cell Regul 2 1991 503 512
71. A. Armulik, A. Abramsson, and C. Betsholtz Endothelial/pericyte interactions Circ Res 97 2005 512 523
72. K.K. Hirschi, S.A. Rohovsky, and P.A. D'Amore PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate J Cell Biol 141 1998 805 814
73. K.K. Hirschi, J.M. Burt, K.D. Hirschi, and C. Dai Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation Circ Res 93 2003 429 437
74. L. Vardouli, E. Vasilaki, E. Papadimitriou, D. Kardassis, and C. Stournaras A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases FEBS J 275 2008 4074 4087
75. N. Rudini, A. Felici, C. Giampietro, M. Lampugnani, M. Corada, and K. Swirsding VE-cadherin is a critical endothelial regulator of TGF-beta signalling EMBO J 27 2008 993 1004
76. C.C. Rider Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily Biochem Soc Trans 34 2006 458 460
77. M. Lyon, G. Rushton, and J.T. Gallagher The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific J Biol Chem 272 1997 18000 18006
78. Q. Chen, P. Sivakumar, C. Barley, D.M. Peters, R.R. Gomes, and M.C. Farach-Carson Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1 J Biol Chem 282 2007 26418 26430
79. X. Zhang, J.P. Gaspard, and D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res 61 2001 6050 6054
80. K. Ishiguro, K. Kadomatsu, T. Kojima, H. Muramatsu, S. Tsuzuki, and E. Nakamura Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions J Biol Chem 275 2000 5249 5252
81. E. Zcharia, R. Zilka, A. Yaar, O. Yacoby-Zeevi, A. Zetser, and S. Metzger Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models FASEB J 19 2005 211 221
82. R. Gallo, C. Kim, R. Kokenyesi, N.S. Adzick, and M. Bernfield Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin J Invest Dermatol 107 1996 676 683
83. H.E. Ryan, J. Lo, and R.S. Johnson HIF-1 alpha is required for solid tumor formation and embryonic vascularization EMBO J 17 1998 3005 3015
84. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
85. N. Tang, L. Wang, J. Esko, F.J. Giordano, Y. Huang, and H.P. Gerber Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis Cancer Cell 6 2004 485 495
86. C.J. Robinson, and S.E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J Cell Sci 114 2001 853 865
87. J. Grunstein, J.J. Masbad, R. Hickey, F. Giordano, and R.S. Johnson Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature Mol Cell Biol 20 2000 7282 7291
88. J. Li, N.W. Shworak, and M. Simons Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites J Cell Sci 115 2002 1951 1959
89. A.P. Elias, and S. Dias Microenvironment changes (in pH) Affect VEGF alternative splicing Cancer Microenviron 1 2008 131 139
90. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, and W. Heim Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
91. A. Sandler, R. Gray, M.C. Perry, J. Brahmer, J.H. Schiller, and A. Dowlati Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2006 2542 2550 (Pubitemid 44917502)
92. A.M. Jubb, A.J. Oates, S. Holden, and H. Koeppen Predicting benefit from anti-angiogenic agents in malignancy Nat Rev Cancer 6 2006 626 635
93. M. Rusnati, and C. Urbinati Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis Curr Pharm Des 15 2009 2946 2957
94. T. Inai, M. Mancuso, H. Hashizume, F. Baffert, A. Haskell, and P. Baluk Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts Am J Pathol 165 2004 35 52
95. M.R. Mancuso, R. Davis, S.M. Norberg, S. O'Brien, B. Sennino, and T. Nakahara Rapid vascular regrowth in tumors after reversal of VEGF inhibition J Clin Invest 116 2006 2610 2621
96. I. Vlodavsky, and Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J Clin Invest 108 2001 341 347 (Pubitemid 32730777)
97. N. Ilan, M. Elkin, and I. Vlodavsky Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis Int J Biochem Cell Biol 38 2006 2018 2039 (Pubitemid 44397619)
98. M.L. Escobar Galvis, J. Jia, X. Zhang, N. Jastrebova, D. Spillmann, and E. Gottfridsson Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate Nat Chem Biol 3 2007 773 778
99. A. Purushothaman, T. Uyama, F. Kobayashi, S. Yamada, K. Sugahara, and A.C. Rapraeger Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis Blood 115 2010 2449 2457
100. Y. Yang, V. Macleod, H.Q. Miao, A. Theus, F. Zhan, and J.D. Shaughnessy Jr. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis J Biol Chem 282 2007 13326 13333
101. L. Lundin, H. Larsson, J. Kreuger, S. Kanda, U. Lindahl, and M. Salmivirta Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis J Biol Chem 275 2000 24653 24660
102. K.D. Johnstone, T. Karoli, L. Liu, K. Dredge, E. Copeman, and C.P. Li Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth J Med Chem 53 2010 1686 1699
103. I. Vlodavsky, N. Ilan, A. Naggi, and B. Casu Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate Curr Pharm Des 13 2007 2057 2073
104. R. Tang, and S.D. Rosen Functional consequences of the subdomain organization of the sulfs J Biol Chem 284 2009 21505 21514
105. J.P. Lai, J.R. Chien, D.R. Moser, J.K. Staub, I. Aderca, and D.P. Montoya hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling Gastroenterology 126 2004 231 248
106. K. Narita, J. Staub, J. Chien, K. Meyer, M. Bauer, and A. Friedl HSulf-1 inhibits angiogenesis and tumorigenesis in vivo Cancer Res 66 2006 6025 6032
107. M. Morimoto-Tomita, K. Uchimura, A. Bistrup, D.H. Lum, M. Egeblad, and N. Boudreau Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer Neoplasia 7 2005 1001 1010
108. N. Song, Y. Huang, H. Shi, S. Yuan, Y. Ding, and X. Song Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis Cancer Res 69 2009 6057 6064
109. K. Pietras, J. Pahler, G. Bergers, and D. Hanahan Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting PLoS Med 5 2008 e19
110. J.I. Greenberg, D.J. Shields, S.G. Barillas, L.M. Acevedo, E. Murphy, and J. Huang A role for VEGF as a negative regulator of pericyte function and vessel maturation Nature 456 2008 809 813
111. J.R. Bishop, K.I. Stanford, and J.D. Esko Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism Curr Opin Lipidol 19 2008 307 313
112. F. Echtermeyer, M. Streit, S. Wilcox-Adelman, S. Saoncella, F. Denhez, and M. Detmar Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4 J Clin Invest 107 2001 R9 R14
113. S.A. Wilcox-Adelman, F. Denhez, and P.F. Goetinck Syndecan-4 modulates focal adhesion kinase phosphorylation J Biol Chem 277 2002 32970 32977
114. D.M. Beauvais, B.J. Ell, A.R. McWhorter, and A.C. Rapraeger Syndecan-1 regulates alphavbeta is blocked by synstatin, a novel peptide inhibitor3 and alphavbeta5 integrin activation during angiogenesis J Exp Med 206 2009 691 705
115. Z. Zhou, J. Wang, R. Cao, H. Morita, R. Soininen, and K.M. Chan Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice Cancer Res 64 2004 4699 4702
116. A. Kadenhe-Chiweshe, J. Papa, K.W. McCrudden, J. Frischer, J.O. Bae, and J. Huang Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation Mol Cancer Res 6 2008 1 9
117. B.P. Woodall, A. Nystrom, R.A. Iozzo, J.A. Eble, S. Niland, and T. Krieg Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity J Biol Chem 283 2008 2335 2343
118. A. Abdollahi, P. Hahnfeldt, C. Maercker, H.J. Grone, J. Debus, and W. Ansorge Endostatin's antiangiogenic signaling network Mol Cell 13 2004 649 663
119. Y. Crawford, and N. Ferrara VEGF inhibition: insights from preclinical and clinical studies Cell Tissue Res 335 2009 261 269
120. L.P. Aiello, R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, and S.T. Shah Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1994 1480 1487
121. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr, M. Feinsod, and D.R. Guyer Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2004 2805 2816
122. N. Ferrara, L. Damico, N. Shams, H. Lowman, and R. Kim Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 2006 859 870
123. E.B. Rodrigues, M.E. Farah, M. Maia, F.M. Penha, C. Regatieri, and G.B. Melo Therapeutic monoclonal antibodies in ophthalmology Prog Retin Eye Res 28 2009 117 144
124. A. Stahl, L. Paschek, G. Martin, N. Feltgen, L.L. Hansen, and H.T. Agostini Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis Graefes Arch Clin Exp Ophthalmol 247 2009 767 773
125. J.B. Jonas, and M. Neumaier Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema Ophthalmic Res 39 2007 139 142
126. R. Simo, E. Carrasco, M. Garcia-Ramirez, and C. Hernandez Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy Curr Diabetes Rev 2 2006 71 98
127. A.M. Patterson, A. Cartwright, G. David, O. Fitzgerald, B. Bresnihan, and B.A. Ashton Differential expression of syndecans and glypicans in chronically inflamed synovium Ann Rheum Dis 67 2008 592 601
128. J.L. Pablos, B. Santiago, M. Galindo, C. Torres, M.T. Brehmer, and F.J. Blanco Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis J Immunol 170 2003 2147 2152
129. H.H. Marti Angiogenesisa self-adapting principle in hypoxia EXS Part 2 2005 163 180
130. S.H. Lee, P.L. Wolf, R. Escudero, R. Deutsch, S.W. Jamieson, and P.A. Thistlethwaite Early expression of angiogenesis factors in acute myocardial ischemia and infarction N Engl J Med 342 2000 626 633
131. F.D. Mataveli, S.W. Han, H.B. Nader, A. Mendes, R. Kanishiro, and P. Tucci Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling Growth Factors 27 2009 22 31
132. M. Rehm, D. Bruegger, F. Christ, P. Conzen, M. Thiel, and M. Jacob Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia Circulation 116 2007 1896 1906
133. F.J. Giordano, P. Ping, M.D. McKirnan, S. Nozaki, A.N. DeMaria, and W.H. Dillmann Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart Nat Med 2 1996 534 539
134. H. Fujii, Z. Sun, S.H. Li, J. Wu, S. Fazel, and R.D. Weisel Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice JACC Cardiovasc Imaging 2 2009 869 879
135. S. Weis, S. Shintani, A. Weber, R. Kirchmair, M. Wood, and A. Cravens Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction J Clin Invest 113 2004 885 894
136. S.M. Bauer, R.J. Bauer, and O.C. Velazquez Angiogenesis, vasculogenesis, and induction of healing in chronic wounds Vasc Endovascular Surg 39 2005 293 306
137. J. Li, Y.P. Zhang, and R.S. Kirsner Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix Microsc Res Tech 60 2003 107 114
138. S.M. Knox, and J.M. Whitelock Perlecan: how does one molecule do so many things? Cell Mol Life Sci 63 2006 2435 2445